122 related articles for article (PubMed ID: 5102089)
1. Cobra venom factor-induced activation of the complement system: developmental, experimental and clinical considerations.
Gewurz H; Pickering RJ; Day NK; Good RA
Int Arch Allergy Appl Immunol; 1971; 40(1):47-58. PubMed ID: 5102089
[No Abstract] [Full Text] [Related]
2. Effect of cobra venom-induced inhibition of complement activity on allograft and xenograft rejection reactions.
Gewurz H; Clark DS; Cooper MD; Varco RL; Good RA
Transplantation; 1967 Sep; 5(5):1296-303. PubMed ID: 4862841
[No Abstract] [Full Text] [Related]
3. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.
Cochrane CG; Müller-Eberhard HJ; Aikin BS
J Immunol; 1970 Jul; 105(1):55-69. PubMed ID: 4246566
[No Abstract] [Full Text] [Related]
4. In vivo abrogation of serum C3 and C5 by administration of cobra venom factor and heterologous anti-C3.
Drake WP; Pokorney DR; Mardiney MR
J Immunol Methods; 1974 Dec; 6(1-2):61-72. PubMed ID: 4215835
[No Abstract] [Full Text] [Related]
5. Inhibition of experimental autoimmune renal tubulointerstitial disease in guinea pigs by depletion of complement with cobra venom factor.
Rudofsky UH; Steblay RW; Pollara B
Clin Immunol Immunopathol; 1975 Jan; 3(3):396-407. PubMed ID: 803234
[No Abstract] [Full Text] [Related]
6. Responses of thymectomized and-or bursectomized chickens to sensitization with Candida albicans.
Fujiwara A; Landau JW; Newcomer VD
Sabouraudia; 1970 May; 8(1):9-17. PubMed ID: 5427156
[No Abstract] [Full Text] [Related]
7. Immune hemolysis and a basic peptide from cobra venom.
Okada H; Campbell W
J Immunol; 1974 Nov; 113(5):1647-9. PubMed ID: 4472944
[No Abstract] [Full Text] [Related]
8. HAEMOLYTIC ACTION OF COBRA VENOM LECITHINASE-A IN THE PRESENCE OF WHOLE GUINEA-PIG SERUM OR LECITHIN.
VAN OSSC ; GOETZE O
Z Immunitats Allergieforsch; 1963 May; 125():75-9. PubMed ID: 14048618
[No Abstract] [Full Text] [Related]
9. Cobra venom-induced hemolysis. Activity levels in sera of patients with neoplastic and other diseases.
Brai M; Osler AG
J Exp Med; 1972 Oct; 136(4):950-5. PubMed ID: 5066513
[No Abstract] [Full Text] [Related]
10. Models of immunologic diseases and disorders.
Good RA; Finstad J; Cain WA; Fish A; Perey DY; Gatti RA
Fed Proc; 1969; 28(1):191-205. PubMed ID: 4974736
[No Abstract] [Full Text] [Related]
11. Anaphylatoxin in its relation to the complement system.
Jensen J
Science; 1967 Mar; 155(3766):1122-3. PubMed ID: 6021911
[TBL] [Abstract][Full Text] [Related]
12. A starfish hemolymph factor which activates vertebrate complement in the presence of cobra venom factor.
Day N; Geiger H; Finstad J; Good RA
J Immunol; 1972 Jul; 109(1):164-7. PubMed ID: 4624674
[No Abstract] [Full Text] [Related]
13. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.
Ballow M; Cochrane CG
J Immunol; 1969 Nov; 103(5):944-52. PubMed ID: 4981797
[No Abstract] [Full Text] [Related]
14. [Development of the lymphoid system. Functional analysis and therapeutic perspectives].
Perey DY; Frommel D; Good RA
Rev Fr Etud Clin Biol; 1969 Nov; 14(9):925-31. PubMed ID: 5365732
[No Abstract] [Full Text] [Related]
15. Congenital and experimentally induced complement deficiency in rabbits.
Fong JS; Good RA
Birth Defects Orig Artic Ser; 1975; 11(1):571-6. PubMed ID: 125122
[TBL] [Abstract][Full Text] [Related]
16. Studies on a hemolytic factor of cobra venom requiring a heat-labile serum factor.
Phillips GB
Biochim Biophys Acta; 1970 Feb; 201(2):364-74. PubMed ID: 5418728
[No Abstract] [Full Text] [Related]
17. Activation of the alternative (properdin) pathway by divalent cations.
Lew FT; Yukiyama Y; Waks HS; Osler AG
J Immunol; 1975 Sep; 115(3):884-8. PubMed ID: 807649
[TBL] [Abstract][Full Text] [Related]
18. Specific hemagglutinin and a modulator of complement in cockroach hemolymph.
Anderson RS; Day NK; Good RA
Infect Immun; 1972 Jan; 5(1):55-9. PubMed ID: 4656356
[TBL] [Abstract][Full Text] [Related]
19. Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom.
Bitter-Suermann D; Dierich M; König W; Hadding U
Immunology; 1972 Sep; 23(3):267-81. PubMed ID: 4214761
[TBL] [Abstract][Full Text] [Related]
20. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
Brade V; Lee GD; Nicholson A; Shin HS; Mayer MM
J Immunol; 1973 Nov; 111(5):1389-400. PubMed ID: 4795621
[No Abstract] [Full Text] [Related]
[Next] [New Search]
